499 related articles for article (PubMed ID: 12461329)
1. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma.
Yarbrough WG
Laryngoscope; 2002 Dec; 112(12):2114-28. PubMed ID: 12461329
[TBL] [Abstract][Full Text] [Related]
2. Familial head and neck cancer: molecular analysis of a new clinical entity.
Yu KK; Zanation AM; Moss JR; Yarbrough WG
Laryngoscope; 2002 Sep; 112(9):1587-93. PubMed ID: 12352668
[TBL] [Abstract][Full Text] [Related]
3. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
4. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
5. Head and neck squamous cell carcinoma in FAMMM syndrome.
Vinarsky V; Fine RL; Assaad A; Qian Y; Chabot JA; Su GH; Frucht H
Head Neck; 2009 Nov; 31(11):1524-7. PubMed ID: 19360740
[TBL] [Abstract][Full Text] [Related]
6. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
7. Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers.
Grüttgen A; Reichenzeller M; Jünger M; Schlien S; Affolter A; Bosch FX
J Pathol; 2001 Jul; 194(3):311-7. PubMed ID: 11439363
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
9. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
Leng K; Schlien S; Bosch FX
J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
[TBL] [Abstract][Full Text] [Related]
10. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
[TBL] [Abstract][Full Text] [Related]
12. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma.
Worsham MJ; Pals G; Schouten JP; Van Spaendonk RM; Concus A; Carey TE; Benninger MS
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):702-8. PubMed ID: 12874067
[TBL] [Abstract][Full Text] [Related]
13. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit.
Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Alam N; Sikdar N; Roy B; Roychoudhury S; Panda CK
J Pathol; 2009 Feb; 217(3):408-19. PubMed ID: 19023882
[TBL] [Abstract][Full Text] [Related]
14. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
[TBL] [Abstract][Full Text] [Related]
15. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
[TBL] [Abstract][Full Text] [Related]
16. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.
Karsai S; Abel U; Roesch-Ely M; Affolter A; Hofele C; Joos S; Plinkert PK; Bosch FX
J Pathol; 2007 Feb; 211(3):314-22. PubMed ID: 17152048
[TBL] [Abstract][Full Text] [Related]
17. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas.
Roesler JM; Livingston EH; Srivatsan E; Chang P; Wang MB
J Surg Res; 1998 Jun; 77(1):50-4. PubMed ID: 9698532
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
19. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
20. p16(INK4A) genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas.
O'Regan EM; Toner ME; Finn SP; Fan CY; Ring M; Hagmar B; Timon C; Smyth P; Cahill S; Flavin R; Sheils OM; O'Leary JJ
Hum Pathol; 2008 Mar; 39(3):452-8. PubMed ID: 18261630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
